Latest Breaking News On - Vertex pharmaceuticals - Page 12 : comparemela.com

StockNews.com downgraded shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a report published on Monday. VRTX has been the subject of several other research reports. Royal Bank of Canada upped their price objective on shares of Vertex Pharmaceuticals from $417.00 to $424.00 and gave the stock […]

Sanfordc bernsteinBrucei sachsWilliam blairCharlesf wagner jrNews ratings for vertex pharmaceuticals dailyVertex pharmaceuticals price performanceWells fargo companyNorges bankVertex pharmaceuticalsAnalyst recommendations for vertex pharmaceuticalsJennison associatesMaxim groupInstitutional trading of vertex pharmaceuticalsVertex pharmaceuticals incorporatedRoyal bankCapital research global investors